{
    "elements": [
        {
            "type": "table",
            "sequence_num": 1,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "CONTINUOUS PERIPHERAL NERVE BLOCKS USING LOCAL ANAESTHETIC"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "12035"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Medical and nursing staff involved in the administration of local anaesthetic for wound infiltration to facilitate post-op pain relief"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "th4 June 2019"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "rd3 June 2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Clinical requirements"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Anaesthetics"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Jayne Somerset Clinical Nurse Specialist, Pain Management"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "MEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Tom Durcan, Pain Consultant"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "1st May 2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Documents Ratification Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "30th May 2019"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: June 2019"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Intranet & Website. Notified on Staff Focus"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 2,
            "data": {
                "url": "12035 Continuous Peripheral Nerve Blocks using Local Anaesthetic 3.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 3,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Pain Consultants"
                    },
                    {
                        "text": "Dr Mark Alexander-Williams"
                    },
                    {
                        "text": "1st May 2019"
                    },
                    {
                        "text": "Anaesthetists"
                    },
                    {
                        "text": "Dr Pete Berry"
                    },
                    {
                        "text": "Pain Service Manager"
                    },
                    {
                        "text": "Lynne Mustard"
                    },
                    {
                        "text": "Pain Pharmacist"
                    },
                    {
                        "text": "Alison Edwards"
                    },
                    {
                        "text": "Resus Officer"
                    },
                    {
                        "text": "Ian Edwards"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Deborah Lepley"
                    },
                    {
                        "text": "Warner Library"
                    },
                    {
                        "text": "15th May 2019"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "08084 Prescribing of Medicines for Inpatient Use 04080 Consent to Examination or Treatment Policy 10010 Medical Equipment Training Policy 10080 Adult patient Observation Policy 06006 Epidural Infusion Analgesia (EIA) and Patient Controlled Epidural Analgesia (PCEA) 18027 Guideline for the management of adult surgical and non-surgical patients receiving an intravenous (iv) infusion of lidocaine 17011 Assessment and Management of Patients with Fractured Ribs"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 13,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Jayne Somerset"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "16th October 2012"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Jayne Somerset"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "30 March 2016"
                    },
                    {
                        "text": "2.1"
                    },
                    {
                        "text": "Jayne Somerset"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "30th September 2016"
                    },
                    {
                        "text": "2.2"
                    },
                    {
                        "text": "Jayne Somerset"
                    },
                    {
                        "text": "Inclusion of point 4.8"
                    },
                    {
                        "text": "18th July 2018"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Jayne Somerset"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "4th June 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 6,
            "data": {
                "is_heading": 1,
                "text": "INDEX"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: For the AAGBI Safety Guideline for the Management of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "text": "Severe Local Anaesthetic Toxicity (2010) follow link below."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 0,
                "text": "https://anaesthetists.org/Home/Resources- publications/Guidelines/Management-of-severe-local-anaesthetic-toxicity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 0,
                "text": "If unable to use link, follow Table 1 and 2"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "text": "Table 1: AAGBI Safety Guideline for the Management of Severe Local"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "text": "Anaesthetic Toxicity (2010"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "text": "Table 2: Suggested regime for lipid emulsion from the AAGBI (2010)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Local Anaesthetic Infusions Guidance for ward use Appendix 3: CNST competency for Elastomeric ON-Q pump Appendix 4: CNST competency for Pain Buster"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "text": "Appendix 5: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "text": "Continuous Peripheral Nerve Blocks using Local Anaesthetic/12035/3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The guideline is designed to provide instruction and guidance in the safe administration of local anaesthetic (LA) used for peripheral nerve blocks. In the event of local anaesthetic systemic toxicity, the guideline also sets out a management plan to treat this."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Peripheral nerve blocks are useful for the management of postoperative and trauma pain. They are used to interrupt pain transmission in the peripheral nervous system. This is achieved by blocking the somatic and sympathetic nerve fibres (those involved in pain transmission), at various sites, after they leave the spinal canal by the administration of local anaesthetic. Local anaesthetic is administered perineurally (around the nerve) either continuously or as a single one-off injection. Their aim is to target a specific area where pain is expected to occur. Appropriate blocks exist for many areas of the body."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "One-off injections of local anaesthetic are often used peri-operatively and provide enhanced pain relief for up to 24 hours, depending on the local anaesthetic used, and the area where they are injected. However, a catheter for continuous infusion of local anaesthetic can be inserted perineurally to extend the analgesia beyond the duration of single shot blocks. These may be left in situ for up to 5 days post-op. In the context of a multimodal approach to pain control, they have proved to be both safe and effective, with the added benefit of reducing the patient's opioid"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "text": "requirement and their related complications. Studies have shown a 40-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "text": "70% reduction in opioid use when used alongside PCA (Patient Controlled Analgesia), compared with PCA alone."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "Nerve fibres differ in their sensitivity to local anaesthetics. Small nerve"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "text": "fibres (those involved in pain transmission) are more sensitive than large nerve fibres (those involved in touch, proprioception and movement)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "text": "while myelinated fibres are blocked before non-myelinated fibres of the same diameter. Thus the loss of nerve function proceeds as loss of pain, temperature, touch, proprioception, and then skeletal muscle tone. This explains why the patient can still feel touch but not experience pain."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "text": "Some blocks will provide pain relief but will not immobilise the limb. This is dependent on the local anaesthetic used and its concentration. For example, higher concentrations may effect skeletal muscle tone and temporarily cause paralysis. For some surgery this is advantageous to immobilise the limb but, for other surgery, early mobilization is essential. The anaesthetist will tailor the local anaesthetic and concentration to patient requirement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 2.4,
                "text": "Local anaesthetics work through two different mechanisms:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "text": "By directly blocking the transmission of pain from nociceptive afferents, by binding to fast sodium channels within the axon membrane, the action potential is prevented."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "text": "By inhibiting the local inflammatory response to injury, which normally sensitises nociceptive receptors and contributes to pain and hyperalgesia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 2.5,
                "text": "Local anaesthetics generally have a lipid-soluble hydrophobic aromatic group and a charged, hydrophilic amide group. The bond between these two groups determines the class of the drug, and may be amide or ester. Examples of amides include Lidocaine, Bupivacaine, and Ropivicaine. These are used within the Trust. Amides are metabolised hepatically. When compared to other types of local anaesthetic, their half-life is longer. Therefore, they can accumulate if given in repeated doses or by infusion, especially where the patient is unable to metabolise and excrete these drugs effectively. This is one example of how LA toxicity can occur."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 2.6,
                "text": "The severity of local anaesthetic systemic toxicity is related to the maximum concentration achieved in the blood and may vary from simple reports of agitation, drowsiness, and metallic taste, to seizures, coma, and cardiac arrest with increasing plasma levels. This forms the basis for patient observation whilst the infusion is in progress."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "prefix": 2.7,
                "text": "The regime to be used for the patient is considered carefully by the anaesthetist, who is responsible for prescribing the LA based on the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "patient's clinical status (such as age, body weight, disease state of patient, concomitant medications etc.) To avoid complications, the lowest flow rate, volume and drug concentration required to produce the desired result is used."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "For all anaesthetic staff, trained nurses, medical staff, therapy staff, and auxiliary staff involved in the care of patients receiving a local anaesthetic to obtain a peripheral nerve block."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Patient and staff related exclusion and inclusion criteria are set out in section 7.1."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Indications for Continuous Peripheral Nerve Blocks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 1,
                "text": "(For further details please use weblink https://www.nysora.com)"
            }
        },
        {
            "type": "table",
            "sequence_num": 38,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Surgical procedure / trauma"
                    },
                    {
                        "text": "Suggested Block"
                    },
                    {
                        "text": "Shoulder trauma / surgery"
                    },
                    {
                        "text": "Interscalene"
                    },
                    {
                        "text": "Unilateral surgical / trauma pain from chest and upper abdomen: cholecystectomy, thoracotomy, renal and breast surgery, ribs fractures"
                    },
                    {
                        "text": "Intrapleural and intercostal"
                    },
                    {
                        "text": "Upper arm surgery"
                    },
                    {
                        "text": "Supraclavicular, Infraclavicular, axillary approaches to brachial plexus nerve block."
                    },
                    {
                        "text": "Lower arm surgery"
                    },
                    {
                        "text": "Axillary approaches to brachial plexus nerve block. Ulnar, radial, and median nerves can be blocked where brachial plexus block does not cover the area"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 39,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "required."
                    },
                    {
                        "text": "Unilateral: Thoracotomy and major breast surgery (T4-5), rib fractures, Nephrectomy (T7)"
                    },
                    {
                        "text": "Thoracic paravertebral"
                    },
                    {
                        "text": "Trunk region"
                    },
                    {
                        "text": "These include rectus sheath blocks for incisions about the midline, e.g. umbilical hernia repairs. The transverse abdominis plane blocks; within the TAP run the afferents of T6 \u2013 L1 that provide sensation to the anterior and lateral abdominal wall so can be effective where incisions are made in this area. The ilioinguinal-iliohypogastric blocks for incisions below the umbilicus, e.g. inguinal hernia repair, orchidopexy, varicocele or hydrocele repair and for obstetric or gynaecological surgery."
                    },
                    {
                        "text": "Hip and femur surgery and fractures"
                    },
                    {
                        "text": "The fascia iliaca block can be considered as an alternative to a lumbar plexus or femoral nerve block, since the femoral nerve and lateral femoral cutaneous nerve (LFCN) lie under the fascia of the iliacus muscle, a sufficient volume of local anesthetic deposited deep to the fascia iliaca may spread underneath the fascia in a medial and lateral direction to reach the femoral nerve and sometimes the LFCN."
                    },
                    {
                        "text": "Femur fractures, knee surgery"
                    },
                    {
                        "text": "Femoral nerve"
                    },
                    {
                        "text": "Total knee replacement, major knee surgery"
                    },
                    {
                        "text": "Femoral and sciatic (parasacral or gluteal or subgluteal approach)"
                    },
                    {
                        "text": "Tibia and fibula surgery and fractures"
                    },
                    {
                        "text": "Sciatic (anterior or gluteal or subgluteal or lateral popliteal approach)"
                    },
                    {
                        "text": "Ankle surgery"
                    },
                    {
                        "text": "Femoral or saphenous + sciatic"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "A variety of factors influence the likelihood and severity of LAST occurring. These include;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "Individual patient risk factors;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "Concurrent medications;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "Location and technique of block used;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "Local anaesthetic used;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "Total anaesthetic dose (product concentration x volume);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "Timeliness of detection;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "text": "Adequacy of treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "LAST can occur"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "text": "where intravascular injection takes place. The effect of this will be seen immediately."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "text": "when there is an accumulation of the drug. This can be from overdose, or where metabolism of the drug is slowed (the pharmacokinetics of a drug may be altered by existing co-morbidities such as cardiac or hepatic failure, alterations in plasma protein binding, or interactions with other drugs. This can occur at any time."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Classic symptoms of LAST include the patients' subjective symptoms due to CNS (Central Nervous System) excitability. LA toxicity signs and symptoms form the basis for patient observation (Refer to section 8)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 1,
                "text": "5.3.1 Early / mild toxicity symptoms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "text": "Confusion;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "Vagueness / restlessness;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "Metallic taste;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "Twitching;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "Auditory changes;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "text": "Tingling or numbness in and / or around the mouth;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "Dizziness or feeling light-headed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "text": "5.3.2 The patient may not disclose these symptoms so always ask if they experience any of the above and ask the patient to let a member of medical staff know immediately if they occur."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 1,
                "text": "5.3.3 Severe Toxicity symptoms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "From central nervous system (CNS) excitability the patient may experience seizures progressing to CNS depression (coma, respiratory arrest);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "text": "In classic descriptions of LAST cardiac toxicity does not precede CNS toxicity. However where LAST is due to accidental intravascular injection, these CNS symptoms maybe bypassed; seizure activity may progress quickly to cardiac excitation (hypertension, tachycardia, ventricular arrthymias);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "text": "In higher blood concentrations, cardiac excitability may be followed by cardiac depression (bradycardia, asystole, decreased contractility, and hypotension)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "There may be large variability in LAST clinical presentation. Seizures are the most common presenting symptom. From research, less than 20% of patients present with signs of early / mild toxicity listed above. It is hard to ascertain if this was due to lack of clinical observation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "For the management and guidance of LAST please refer to Appendix  These are the guidelines set out by the Association of Anaesthetists of Great Britain and Ireland (AAGBI) in 2010. They are the most up to date guidelines for the treatment of LAST. Management consists of recognition, immediate management, treatment, and follow-up."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "For the infusion of intravenous lipid emulsion, which is used in LAST, there is not a set regime for the MEHT Trust. The table and link found in the Appendix section 1 shows details of suggested infusions by the AAGBI. This is not a standard of medical care. The ultimate judgement with regard to a particular clinical procedure or treatment plan must be made by the clinician in the light of the clinical data presented and the diagnostic and treatment options available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "Early detection remains the most effective way of reducing the frequency and severity of LAST. This is why patient observation is paramount. (Refer to Section 8)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "Intralipid 20% solution is stocked in the following areas if required. A&E"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "text": "Majors, main theatres drug room, neonatal unit, day stay theatre, and Burns"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "ICU."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Medical and nursing staff administering local anaesthetics must be trained in its use. This includes the exclusion criteria, adverse effects; namely LAST and the actions to be taken if these occur. Any shortfall in knowledge and competence should be recognised by staff and they should contact the IPMS should they need further training."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Local anaesthetic infusions are administered via a delivery device. Staff involved in this should be competent to use the delivery device. This will include the elastomeric pump, which may be used for the procedure. Competency in using these delivery devices is essential prior to using them. Refer to the \u2018Medical Equipment Training Policy, register number 10010. Both CNST competencies are attached to this guideline (See Appendices 3 and 4)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "The IPMS (Integrated Pain Management Service) is available for advice and consultation via the pager system, and through the hospital referral system."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "Training and education is provided by the IPMS, both formally and informally for all clinical staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "Medical staff will be informed of revised guidelines via senior medical staff within the IPMS at audit meetings and twice yearly teaching sessions for all FY1 and FY2 doctors."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Pre \u2013 Procedure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Patient is selected considering the exclusion / inclusion criteria."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "7.1.1  Exclusion criteria:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "Allergy to LA;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "text": "Patient refusal;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "text": "Unqualified ward staff;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "Infection;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "Existing or potential coagulopathy;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "Suspected Compartment Syndrome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Procedure is explained and consent is given by the patient which must be"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "documented."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "text": "(Refer to \u2018Consent to examination or treatment Policy' register number 04080)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "The catheter is sited aseptically."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "The appropriate delivery device is chosen and in working order. Appropriate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "safety checks carried out on device. See separate Competency Statement according to device chosen. (Refer to Appendix 3 and 4)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "Ensure the wound catheter is clearly marked, along with the administration line used that is connected to delivery device. This is to reduce the risk of intravenous administration."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "Check the insertion site of catheter; checking to see if the dressing is intact, there are no signs of leakage or swelling."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "Ensure the patient has working intravenous (IV) access."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "prefix": 7.8,
                "text": "Check ward staff are competent to care for a patient with a local anaesthetic infusion and corresponding delivery device."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "prefix": 7.9,
                "text": "Ensure the infusion regime is prescribed clearly."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Ensure nursing staff on the ward are able to care for a patient with a LA (local anaesthetic) infusion and are able to use the delivery device chosen. Please see the CNST competency check sheets for Elastomeric pumps in Appendix 3, and the CNST competency check sheet for the pain buster device. (Refer to Appendix 4)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Ensure IV access present and patent."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Check prescription of LA against what the patient is receiving. Check pump program is correct."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "LA toxicity signs and symptoms form the basis for patient observation. (Refer to section 5.3.1 and 5.3.3)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "prefix": 8.5,
                "text": "A guidance sheet has been made for quick reference which can be laminated"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "and used in clinical areas. (Refer to Appendix 2)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 1,
                "text": "Patient observations for continuous infusions include:"
            }
        },
        {
            "type": "table",
            "sequence_num": 104,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Below 5mls/hour"
                    },
                    {
                        "text": "5mls/hour and above"
                    },
                    {
                        "text": "Catheter site inspection"
                    },
                    {
                        "text": "Ensure IV access present and patent"
                    },
                    {
                        "text": "General post-op observations; BP, pulse, RR, Temp + PAR Score"
                    },
                    {
                        "text": "Catheter site inspection"
                    },
                    {
                        "text": "Pump in working order"
                    },
                    {
                        "text": "General post-op observations; BP, pulse, RR, Temp & PAR Score"
                    },
                    {
                        "text": "These are to be carried out 2-4 hourly depending on clinical need."
                    },
                    {
                        "text": "Pump in working order"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "These are to be carried out 1-4 hourly depending on clinical need"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 1,
                "prefix": 8.6,
                "text": "For continuous LA infusion with BOLUS option:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "text": "Ensure IV access present and patent."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "text": "General observations as above and additional as stated below."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Only nurses trained to use elastomeric devices can care for patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "text": "Only the nurse looking after the patient may deliver the bolus dose."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "Bolus doses of LA are high in volume. LAST is more likely to occur when bolus doses are given."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "text": "Observations post bolus, include BP, Pulse, RR, and signs / symptoms of LAST. These observations are to be taken immediately post bolus delivery, and then 15 minutes post bolus and 30 minutes post bolus. If unintentional IV administration occurs LAST will occur immediately. LAST due to overdose can be generally picked up within 30 minutes post bolus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "prefix": 8.7,
                "text": "If LAST is suspected STOP infusion / bolus immediately. Call the on-call anaesthetist. Ensure resuscitation equipment is close to patient. If the patient becomes unresponsive, call the resuscitation team immediately. Consider treatment steps according to the tables 1 and 2 in Appendix 1."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "prefix": 8.8,
                "text": "Removal of the LA catheter is carried out aseptically. Inspection of the catheter carried out to ensure tip is intact. If the patient has a temperature less than or equal to 38.5\u00b0C, send tip to microbiology for culture and sensitivity."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Approved guidelines are accessible from the staff intranet."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "In addition, the clinical guideline will be disseminated to the ward through pain link nurses within their clinical areas"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "The new guideline will be introduced to anaesthetic staff through anaesthetic meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Medical staff will be informed of revised guidelines via senior medical staff within the IPMS at audit meetings and twice yearly teaching sessions for all FY1 and FY2 doctors."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "Pharmacy are involved and made aware of the new guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The catheter used for the LA infusion is sited aseptically."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Trust protocol for prevention of cross infection is to be adhered to prior to, during and after siting of the LA catheter."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Disposable equipment is to be disposed of appropriately according to waste segregation policy, i.e. clinical waste."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "A Datix should be completed for non-compliance with this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "Incidence of clinical risk or patient complaints resulting from non-compliance with this guideline are to be recorded via the central risk events database and PALS (Patient Advisory Liaison Service) if involved."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Pain link nurses on the wards are to monitor LA infusion use and report any adverse events or training needs to the IPMS. Clinical meetings for link nurses are held three times a year. Potential audit discussion and problems can be evaluated in this meeting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "The IPMS manager and lead consultant will liaise at corporate level to put strategies in place to address issues."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to Appendix 5)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "text": "Bamigboye, A, Hofmeyr, G (2009) Local anaesthetic wound infiltration and abdominal nerves block during caesarean section for postoperative pain relief. Cochrane Database of Systematic Reviews, issue 3, Art. No: CD006954. DOI: 10.1002/14651858.CD006954.pub2."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "Anaesthesia UK (2005) Upper limb nerve blocks [online]"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "text": "Available at: http://www.frca.co.uk/article.aspx?articleid=100446 New York School of Regional Anesthesia [online] www.nysora.com"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "prefix": 35.0,
                "text": "Neal, Joseph M., Bernards, C.M., Butterworth, J.F., Di Gregorio, G., Drasner, K., Hejtmanek, M.R., Mulroy, M.F., Rosenquist, R.W., Weinberg, G. (2010) \u2018Asra Practice Advisory on Local Anaesthetic Systemic Toxicity' Regional Anaesthesia & Pain Medicine:  (2): 152-161"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "Association of Anaesthetists of Great Britain and Ireland (2010) AAGBI Safety Guideline: Management of Severe Local Anaesthetic Toxicity. London: AAGBI https://anaesthetists.org/Home/Resources- publications/Guidelines/Management-of-severe-local-anaesthetic-toxicity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "text": "Association of Anaesthetists of Great Britain and Ireland (2010) AAGBI Safety Guideline: Management of Severe Local Anaesthetic Toxicity. Accompanying notes. London: AAGBI  https://anaesthetists.org/Home/Resources- publications/Guidelines/Management-of-severe-local-anaesthetic-toxicity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "text": "Lim Y.C., Choo,C.Y., Phua,S.K.D., Sim Y.Y., Ng J.J., Yoong C.S. (2011) \u2018Prospective Audit of complications related to Peripheral Nerve Blocks' (Conference Abstract) Regional Anaesthesia and Pain Medicine, 36(5) supplement 2 (E258), 1098-7339"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "text": "Chelly, J.E., Ghisi,D., Fanelli,A. (2010) \u2018Continuous peripheral nerve blocks in acute pain management' British Journal of Anaesthesia 105 (S1): i86-i96."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "text": "Jeng, C, Rosenblatt. M (2019) Overview of peripheral nerve blocks. UpToDate [online] https://www.uptodate.com/contents/overview-of-peripheral-nerve- blocks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "text": "Ilfeld, B.M. (2017) \u2018Continuous Peripheral Nerve Blocks: An Update of the Published Evidence and Comparison with Novel, Alternative Analgesic Modalities'. Anesthesia & Analgesia: 124(1): p308\u2013335)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1 Table 1"
            }
        },
        {
            "type": "table",
            "sequence_num": 140,
            "data": {
                "num_rows": 12,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "AAGBI Safety Guideline Management of Severe Local Anaesthetic Toxicity"
                    },
                    {
                        "text": "Step 1 RECOGNITION"
                    },
                    {
                        "text": "Sudden alteration in mental status, severe agitation or loss of consciousness, with or without convulsions Cardiovascular collapse: sinus bradycardia, conduction blocks, asystole and ventricular tachyarrhythmias may all occur Local anaesthetic (LA) toxicity may occur some time after an initial injection"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Step 2 IMMEDIATE"
                    },
                    {
                        "text": "Stop injecting / infusing the local anaesthetic Call for help, if unresponsive start rescusitation procedures Maintain the airway and, if necessary, secure it with a tracheal tube Give 100% oxygen and ensure adequate lung ventilation (hyperventilation may help by increasing plasma pH in the presence of metabolic acidosis) Confirm or establish intravenous access Control seizures: give a benzodiazepine, thiopental or propofol in small incremental doses Assess cardiovascular status throughout Consider drawing blood for analysis, but do not delay definitive treatment to do this"
                    },
                    {
                        "text": "MANAGEMENT"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Step 3 TREATMENT"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Start cardiopulmonary resuscitation (CPR) using standard protocols Manage arrhythmias using the same protocols, recognising that arrhythmias may be very refractory to treatment Consider the use of cardiopulmonary bypass if available Give intravenous lipid emulsion (following the regimen below) Continue CPR throughout treatment with lipid emulsion Recovery from LA- induced cardiac arrest may take >1 h Propofol is not a suitable substitute for lipid emulsion Lidocaine should not be used as an anti-arrhythmic therapy"
                    },
                    {
                        "text": "Use conventional therapies to treat: hypotension bradycardia tachyarrhythmia Consider intravenous lipid emulsion(following the regimen below) Propofol is not a suitable substitute for lipid emulsion Lidocaine should not be used as an anti-arrhythmic therapy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Step 4 FOLLOW-UP"
                    },
                    {
                        "text": "Arrange safe transfer to a clinical area with appropriate equipment and suitable staff until sustained recovery is achieved Exclude pancreatitis by regular clinical review, including daily amylase or lipase assays for two days Report cases as follows: in the United Kingdom to the National Patient Safety Agency (via www.npsa.nhs.uk) If Lipid has been given, please also report its use to the international registry at www.lipidregistry.org. Details may also be posted at www.lipidrescue.org"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "text": "to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "text": "Continuous Peripheral Nerve Blocks using Local Anaesthetic/12035/3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 1,
                "text": "Table 2: Suggested regime for Lipid emulsion from the AAGBI (2010)"
            }
        },
        {
            "type": "table",
            "sequence_num": 145,
            "data": {
                "num_rows": 11,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Immediately"
                    },
                    {
                        "text": "Give an initial intravenous bolus injection of 20% lipid emulsion 1.5 ml.kg\u20131 over 1 min"
                    },
                    {
                        "text": "and"
                    },
                    {
                        "text": "Start an intravenous infusion of 20% lipid emulsion at 15 ml.kg\u20131.h\u20131"
                    },
                    {
                        "text": "after 5 min"
                    },
                    {
                        "text": "Give a maximum of two repeat boluses (same dose) if: cardiovascular stability has not been restored or an adequate circulation deteriorates Leave 5 min between boluses A maximum of three boluses can be given (including the initial bolus)"
                    },
                    {
                        "text": "and"
                    },
                    {
                        "text": "Continue infusion at same rate, but: Double the rate to 30 ml.kg\u20131.h\u20131 at any time after 5 min, if: cardiovascular stability has not been restored or an adequate circulation deteriorates Continue infusion until stable and adequate circulation restored or maximum dose of lipid emulsion given"
                    },
                    {
                        "text": "Do not exceed a maximum cumulative dose of 12 ml.kg\u20131"
                    },
                    {
                        "text": "An approximate dose regimen for a 70-kg patient would be as follows:"
                    },
                    {
                        "text": "Immediately"
                    },
                    {
                        "text": "Give an initial intravenous bolus injection of 20% lipid emulsion 100 ml over 1 min"
                    },
                    {
                        "text": "and"
                    },
                    {
                        "text": "Start an intravenous infusion of 20% lipid emulsion at 1000 ml.h\u20131"
                    },
                    {
                        "text": "after 5 min"
                    },
                    {
                        "text": "Give a maximum of two repeat boluses of 100 ml"
                    },
                    {
                        "text": "and"
                    },
                    {
                        "text": "Continue infusion at same rate but double rate to 2000 ml.h\u20131 if indicated at any time"
                    },
                    {
                        "text": "Do not exceed a maximum cumulative dose of 840 ml"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 1,
                "text": "Local Anaesthetic Infusions guidance for ward use"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 1,
                "text": "This includes all infusions delivered through Elastomeric device. Patient Observations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 1,
                "text": "Patient observations for continuous infusions only"
            }
        },
        {
            "type": "table",
            "sequence_num": 150,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Below 5mls/hr"
                    },
                    {
                        "text": "5mls/hr and above"
                    },
                    {
                        "text": "Catheter site inspection"
                    },
                    {
                        "text": "Ensure IV access present and patent"
                    },
                    {
                        "text": "General post-op observations; BP, pulse, RR, Temp"
                    },
                    {
                        "text": "Catheter site inspection"
                    },
                    {
                        "text": "Pump in working order"
                    },
                    {
                        "text": "General post-op observations; BP, pulse, RR, Temp"
                    },
                    {
                        "text": "These are to be carried out 2-4 hourly depending on clinical need."
                    },
                    {
                        "text": "Pump in working order"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "These are to be carried out 1-4 hourly depending on clinical need"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 1,
                "text": "For continuous LA infusion with BOLUS option:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "text": "ii.  Bolus doses of LA are high in volume. LA toxicity is more likely to occur when bolus doses are given."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "iv.  Observations post bolus, include BP, Pulse, RR, and signs / symptoms of LA toxicity."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "These observations are to be taken immediately post bolus delivery, and then 15 minutes post bolus and 30 minutes post bolus. If unintentional IV administration occurs LA toxicity will occur immediately. LA toxicity due to overdose can be generally picked up within 30 minutes post bolus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "If local anaesthetic toxicity is suspected STOP the infusion immediately. Call the on-call anaesthetist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "Ensure resuscitation equipment is close to patient. Intralipid (lipid emulsion) - the antidote for LA toxicity is kept in main theatre recovery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "text": "LA toxicity signs and symptoms include:"
            }
        },
        {
            "type": "table",
            "sequence_num": 158,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Early mild toxicity"
                    },
                    {
                        "text": "Severe Toxicity"
                    },
                    {
                        "text": "Confusion Vagueness / restlessness Twitching Metallic taste Tingling or numbness in and / or around the mouth Auditory changes Dizziness or feeling light-headed"
                    },
                    {
                        "text": "Tonic-clonic convulsions Loss of consciousness Respiratory depression / arrest Tachycardia & Ventricular arrhythmias Bradycardia / hypotension Asystole (Cardiac Arrest) Cardiac symptoms usually develop after CNS symptoms if LA serum concentration rises slowly, but may develop first if LA toxicity is due to accidental iv injection."
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "The patient may not divulge these symptoms so always ask if they experience any of the above and ask the patient to let a member of medical staff know immediately if they occur."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 1,
                "text": "Removal of catheter is instructed by the surgeon / anaesthetist. Remove using aseptic non touch technique. Grasp catheter and gently pull. If any resistance occurs, then STOP. Contact the surgeon / anaesthetist immediately. Integrated Pain Management Service JS/2019"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "text": "Continuous Peripheral Nerve Blocks using Local Anaesthetic/12035/3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: CNST competency for Elastomeric ON-Q pump"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 1,
                "text": "MEDICAL DEVICE / EQUIPMENT COMPETENCY SELF ASSESSMENT STATEMENT"
            }
        },
        {
            "type": "table",
            "sequence_num": 165,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Equipment category / name:"
                    },
                    {
                        "text": "On-Q Elastomeric Infusion Pump"
                    },
                    {
                        "text": "Competency Statement Number:"
                    },
                    {
                        "text": "CS-MISC-014-14"
                    },
                    {
                        "text": "Areas where equipment used: Recovery & dedicated surgical wards"
                    },
                    {
                        "text": "Staff groups using this equipment:"
                    },
                    {
                        "text": "Qualified recovery staff, Pain clinical nurse specialists, Anaesthetists and qualified nursing staff"
                    },
                    {
                        "text": "Training level:"
                    },
                    {
                        "text": "Complex Intermediate Basic External / DCCT DCCT / Super-user Self/ Peer"
                    },
                    {
                        "text": "Risk Level"
                    },
                    {
                        "text": "High Medium Low"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "text": "The statements below are designed to assess your competence to use this device. You should self-assess your competency after you have received the relevant training. Responsibility for use of the equipment remains with you, so if you are in any doubt about your competence to use the device, you must seek additional training in liaison with your line manager / supervisor and then re-assess your competence against the statement. Sources of training support include the product operating manual and training from peers, super-users or Clinical Technicians as appropriate."
            }
        },
        {
            "type": "table",
            "sequence_num": 167,
            "data": {
                "num_rows": 29,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions to ask yourself: Are you safe using this equipment? Do you know the following?"
                    },
                    {
                        "text": "Assessment"
                    },
                    {
                        "text": "Part 1 All staff"
                    },
                    {
                        "text": "1"
                    },
                    {
                        "text": "Outline exclusion criteria for local anaesthetic infusions"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "2"
                    },
                    {
                        "text": "Identify complications of a local anaesthetic infusion; specifically local anaesthetic toxicity and action to be taken if adverse effects occur"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "3"
                    },
                    {
                        "text": "Check integrity of the system"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "4"
                    },
                    {
                        "text": "Outlines the monitoring of a patient whilst local anaesthetic infusing"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "5"
                    },
                    {
                        "text": "Demonstrate how to check the pump is working"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "6"
                    },
                    {
                        "text": "Demonstrate how to turn pump off by using clamp"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "7"
                    },
                    {
                        "text": "Explain how the pump operates"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "8"
                    },
                    {
                        "text": "Understand that no alterations are to be made to the rate of infusion this is carried out by Anaesthetist or CNS only."
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "9"
                    },
                    {
                        "text": "Dispose safely of the sealed system"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "10"
                    },
                    {
                        "text": "Demonstrate removal of infusion catheter"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "11"
                    },
                    {
                        "text": "Demonstrate disposal / cleaning method / Storage of pump"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Demonstrates the completion of infusion in patients records"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "13"
                    },
                    {
                        "text": "Competency \u201dPerforms nursing care of the person requiring \u201cREGIONAL BLOCKADE\u201d & record of supervised practise completed on __/__/__"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "Part 2 Anaesthetists siting perineural catheter and commencing infusion"
                    },
                    {
                        "text": "14"
                    },
                    {
                        "text": "Identify exclusion criteria for local anaesthetic administration"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "15"
                    },
                    {
                        "text": "Able to identify and locate equipment required"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "16"
                    },
                    {
                        "text": "Demonstrate how to unlock the pump with specific ON-Q key to make changes to the rate of the infusion"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "17"
                    },
                    {
                        "text": "Identify and site catheter in optimal area to maximise pain relief"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "18"
                    },
                    {
                        "text": "Able to secure catheter using appropriate dressing"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "19"
                    },
                    {
                        "text": "Prescribe regime to be used; Concentration of local anaesthetic: Continuous or variable infusion"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "20"
                    },
                    {
                        "text": "State the safety checks to be performed prior to using device"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "21"
                    },
                    {
                        "text": "Use the \u2018select-a-flow' dial and ensure the safe removal and storage key"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "22"
                    },
                    {
                        "text": "Position the fixed flow rate to the patient's skin"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "23"
                    },
                    {
                        "text": "Protect the filter from exposure to water when necessary"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "24"
                    },
                    {
                        "text": "Able to initiate bolus / infusion"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": "25"
                    },
                    {
                        "text": "Able to purge air from line"
                    },
                    {
                        "text": "Yes / No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 1,
                "text": "You must be able to answer yes to all questions relevant to your role to consider yourself competent. If you are competent, you should date and sign your  Diagnostic & Therapeutic Equipment Competency Record  for this equipment. If you are not competent, please identify this on your record, signing and dating the record appropriately, and discuss with your manager how and when your training needs will be met."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 1,
                "text": "Your line manager should retain your Diagnostic & Therapeutic Equipment Competency Record. Self - assessment is undertaken on a one-off basis but will be reviewed annually at appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 1,
                "text": "Appendix 4: CNST competency for Pain Buster"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 1,
                "text": "MEDICAL DEVICE / EQUIPMENT COMPETENCY SELF ASSESSMENT STATEMENT"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 0,
                "text": "Self assessment of competency should be measured against the statements below. These statements are designed to indicate competence to use this device. Responsibility for use of the equipment remains with"
            }
        },
        {
            "type": "table",
            "sequence_num": 173,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Equipment name:"
                    },
                    {
                        "text": "PainBuster Device. Used for continuous administration of Local Anaesthetic solution."
                    },
                    {
                        "text": "Competency Statement Number:"
                    },
                    {
                        "text": "CS581"
                    },
                    {
                        "text": "Areas where equipment used: Recovery, and dedicated ward areas"
                    },
                    {
                        "text": "Theatre"
                    },
                    {
                        "text": "Staff groups who use this equipment:"
                    },
                    {
                        "text": "Qualified Recovery Staff, Pain Clinical Nurse Specialists, Qualified Nursing staff, and Anaesthetists"
                    },
                    {
                        "text": "Training level:"
                    },
                    {
                        "text": "High"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 1,
                "text": "High Risk Device  STOP - Do not use this item unless you are competent to do so"
            }
        },
        {
            "type": "image",
            "sequence_num": 175,
            "data": {
                "url": "12035 Continuous Peripheral Nerve Blocks using Local Anaesthetic 3.0.002.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "the user, so if you are in any doubt regarding your competence to use the device, you should seek education to bring about improvement. Various methods including self-directed learning; coaching and formal training may be initiated. Consider local resources, product operating manual & discussion with colleagues / manager."
            }
        },
        {
            "type": "table",
            "sequence_num": 177,
            "data": {
                "num_rows": 9,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions to ask yourself: Are you safe using this equipment? Do you know how to:"
                    },
                    {
                        "text": "Assessment"
                    },
                    {
                        "text": "Qualified Surgeon (1-7 only)"
                    },
                    {
                        "text": "1"
                    },
                    {
                        "text": "Identify exclusion criteria for local anaesthetic administration?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "2"
                    },
                    {
                        "text": "Able to identify and locate equipment required; catheter, device, solution?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "3"
                    },
                    {
                        "text": "Identify and site catheter in optimal area to maximize pain relief?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "4"
                    },
                    {
                        "text": "Able to secure catheter using appropriate dressing to reduce risk of dislodgement?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "5"
                    },
                    {
                        "text": "Prescribe regime to be used; Continuous infusion and concentration of local anaesthetic?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "6"
                    },
                    {
                        "text": "State the safety checks to be performed prior to using the PainBuster device?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "7"
                    },
                    {
                        "text": "Able to initiate infusion?"
                    },
                    {
                        "text": "Yes/No"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 178,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Qualified competent Recovery and Ward Staff (8-16 only)"
                    },
                    {
                        "text": "8"
                    },
                    {
                        "text": "Outline inclusion exclusion criteria for Local Anaesthetic infusions?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "9"
                    },
                    {
                        "text": "Identify complications of a Local Anaesthetic infusion; specifically Local Anaesthetic Toxicity, and action to be taken if adverse effects occur?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "10"
                    },
                    {
                        "text": "Aware that different concentrations and volumes of local anaesthetic are used for different blocks and why?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "11"
                    },
                    {
                        "text": "Outlines the monitoring of a patient whilst Local Anaesthetic infusion in progress?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Demonstrates how to turn pump off by clamping infusion line?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "13"
                    },
                    {
                        "text": "Demonstrates removal of wound catheter?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "14"
                    },
                    {
                        "text": "Demonstrates disposal of pump and administration line?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "15"
                    },
                    {
                        "text": "Demonstrates the completion of infusion in the patients' records?"
                    },
                    {
                        "text": "Yes/No"
                    },
                    {
                        "text": "16"
                    },
                    {
                        "text": "Competency \u201cPerforms nursing care of the person requiring \u201cREGIONAL BLOCKADE\u201d & Record of Supervised Practice completed on ____/____/____"
                    },
                    {
                        "text": "Yes/No"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 1,
                "text": "You must be able to answer yes to all questions relevant to your role to consider yourself competent. If you are competent, you should date and sign your  Diagnostic & Therapeutic Equipment Competency Record for this equipment. If you are not competent, please identify this on your record, signing and dating the record appropriately, and discuss with your manager how and when your training needs will be met."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 180,
            "data": {
                "is_heading": 1,
                "text": "Your line manager should retain your Diagnostic & Therapeutic Equipment Competency Record. Self - assessment is undertaken on a one-off basis but will be reviewed annually at appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 0,
                "text": "Continuous Peripheral Nerve Blocks using Local Anaesthetic/12035/3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 0,
                "text": "Continuous Peripheral Nerve Blocks using Local Anaesthetic/12035/3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 184,
            "data": {
                "is_heading": 1,
                "text": "Appendix 5: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 185,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Continuous Peripheral Nerve Blocks using Local Anaesthetic (12035)"
            }
        },
        {
            "type": "table",
            "sequence_num": 186,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": "Review and update yes"
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Additions to block list section 3.0"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Review of information to ensure current and evidenced based"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients receiving blocks and staff understanding what is required."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "no"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Review with list of consultees (pages 1& 2)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 188,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Jayne Somerset"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "CNS Governance Pain"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "1st May 2019"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": ""
            }
        }
    ]
}